
Congrats to Dr Reed O’Connor and Dr chambers @LAURAJMOULTON on getting the FWC Harold and Barbara Rosenbaum family award @GYNCancer to study probiotic and dietary fiber to potentiate immunotherapy in cervical cancer @osugynonc @OSUCCC_James

Gynecologic oncologist at the James Cancer Hospital at the Ohio State University, clinical trials to improve patients lives. my opinions not OSU’s.

Congrats to Dr Reed O’Connor and Dr chambers @LAURAJMOULTON on getting the FWC Harold and Barbara Rosenbaum family award @GYNCancer to study probiotic and dietary fiber to potentiate immunotherapy in cervical cancer @osugynonc @OSUCCC_James

What an amazing day- installation of Floor Backes as the Larry Copeland Professor at OSU James! Thanks Cope for your generosity and tremendous contributions to #gynonc and congrats @FBackesMD- so well deserved! @GOG @SGO_org @IGCSociety @acog

So honored to receive the Larry J. Copeland, MD Endowed Professorship in Gynecologic Oncology @osugynonc @OSUCCC_James

Platinum sensitivity does not apply in endometrial cancer. Platinum-free interval (PFI) is associated with response to next therapy but is NOT better for platinum versus no platinum treatment. @gynoncjnls . Https://www.sciencedirect.co…





@DrKatyMoore puts it all so well together and stresses the importance of predictive biomarkers to inform us which ADC to use for each individual patient and how to sequence them @SGO_org @myESMO #ESMO2024 #ESMO24

@DrKatyMoore puts it all so well together and stresses the importance of predictive biomarkers to inform us which ADC to use for each individual patient and how to sequence them @SGO_org @myESMO #ESMO2024 #ESMO24

Exciting new options on the horizon for patients with recurrent ovarian, endometrial and cervical cancer : 3 Trop2 targeting ADCs were presented #ESMO2024 with relatively similar response rates (30-40%) and DOR > 6 months.




